Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products

被引:1
|
作者
Wieczorowska-Tobis, K [1 ]
Brelinska, R
Witowski, J
Passlick-Deetjen, J
Schaub, TP
Schilling, H
Breborowicz, A
机构
[1] Univ Med Sci, Dept Pathophysiol, PL-60781 Poznan, Poland
[2] Univ Med Sci, Dept Histol & Embryol, PL-60781 Poznan, Poland
[3] Fresenius Med Care, Bad Homburg, Germany
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2004年 / 24卷 / 01期
关键词
glucose degradation products; peritoneal dialysis fluids; biocompatibility; peritoneal eosinophilia; animal models;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Acidic pH and the presence of glucose degradation products (GDP) are believed to compromise the biocompatibility of peritoneal dialysis fluids (PDF). The present study examines the effects of long-term exposure to GDP and low pH by comparing conventional PDF and a new, neutral pH, low GDP solution. Methods: All experiments were performed using a chronic infusion model of dialysis in nonuremic rats. The animals were treated for 6 weeks with 2 daily injections of 4.25% glucose-containing PDF. The following PDF were tested: CAPD3 (single-chamber bag, low pH, high GDP), CAPD3 pH 7.4 (single-chamber bag, neutral pH, high GDP), CAPD3-Balance (double-chamber bag, neutral pH, low GDP). All test solutions were obtained from Fresenius Medical Care, Bad Homburg, Germany. Results: After 6 weeks of exposure, peritoneal permeability to water, urea, creatinine, glucose, and sodium, assessed by peritoneal equilibration test, was similar in all groups. However, compared to other PDF; dialysis with CAPD3-Balance was associated with reduced concentrations of protein and hyaluronan in the dialysate, decreased peritoneal eosinophilia, and reduced dialysate levels of chemokines CCL2/MCP-1 and CCL5/RANTES. Morphologic changes in the peritoneal membrane of CAPD3-Balance-treated animals were much less pronounced and included reduced vascular density, preservation of the mesothelial monolayer and intercellular junction, and no reduplication of the submesothelial basement membrane. Conclusions: Anew generation of PDF with physiologic pH and low GDP level produce less irritation to the peritoneal membrane and better preserve its structural integrity. This effect seems to be related predominantly to minimized GDP concentrations.
引用
收藏
页码:48 / 57
页数:10
相关论文
共 50 条
  • [1] Peritoneal dialysis solutions low in glucose degradation products evidence for clinical benefits
    Tomo, Tadashi
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 : S123 - S127
  • [2] Glucose degradation products and peritoneal membrane function
    Witowski, J
    Bender, TO
    Gahl, GM
    Frei, U
    Jörres, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (02): : 201 - 205
  • [3] Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products
    Mortier, S
    De Vriese, AS
    Van de Voorde, J
    Schaub, TP
    Passlick-Deetjen, J
    Lameire, NH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 480 - 489
  • [4] Detection of glucose degradation products in peritoneal dialysis solutions.
    Schalkwijk, CG
    Posthuma, N
    ter Wee, PM
    Teerlink, T
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1627 - 1627
  • [5] EFFECT OF GLUCOSE DEGRADATION PRODUCTS ON PERITONEAL FUNCTION IN RATS ON CHRONIC PERITONEAL DIALYSIS
    Kuzlan-Pawlaczyk, Malgorzata
    Pawlaczyk, Krzysztof
    Polubinska, Alicja
    Wisniewska-Elnur, Justyna
    Gorska, Kinga
    Wu, George
    Paul, Tam
    Carlsson, Ola
    Wieslander, Anders
    Czekalski, Stanislaw
    Breborowicz, Andrzej
    NEPHROLOGY, 2005, 10 : A66 - A67
  • [6] Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats
    Ikehara, O
    Nishimura, H
    Naito, T
    Higuchi, C
    Sanaka, T
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 100 (01): : E30 - E39
  • [7] NEUTRAL SOLUTION LOW IN GLUCOSE DEGRADATION PRODUCTS IS ASSOCIATED WITH LESS PERITONEAL FIBROSIS AND VASCULAR SCLEROSIS IN PATIENTS RECEIVING PERITONEAL DIALYSIS
    Kawanishi, Kunio
    Honda, Kazuho
    Tsukada, Misao
    Oda, Hideaki
    Nitta, Kosaku
    PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (03): : 242 - 251
  • [8] Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells
    Witowski, J
    Korybalska, K
    Ksiazek, K
    Wisniewska-Elnur, J
    Jörres, A
    Lage, C
    Schaub, TP
    Passlick-Deetjen, J
    Breborowicz, A
    Grzegorzewska, A
    Ksiazek, A
    Liberek, T
    Lichodziejewska-Niemierko, M
    Majdan, M
    Rutkowski, B
    Stompór, T
    Sulowicz, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 917 - 924
  • [9] Glucose degradation products and the peritoneal mesothelium
    Jörres, A
    Bender, TO
    Witowski, J
    PERITONEAL DIALYSIS INTERNATIONAL, 2000, 20 : S19 - S22
  • [10] Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat
    Park, SH
    Lee, EG
    Kim, IS
    Kim, YJ
    Cho, DK
    Kim, YL
    PERITONEAL DIALYSIS INTERNATIONAL, 2004, 24 (02): : 115 - 122